Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.

Br J Dermatol · 2014 · PMC4232897 · PMID 24147933

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Overall, the ATX-101 2 mg cm −2 dose showed a trend towards better efficacy outcomes compared with the 1 mg cm −2 dose but it should be noted that this study was not designed to compare the two ATX-101 doses.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.